KANSAS CITY, Kan., Feb. 26, 2019 /PRNewswire/ -- The University of Kansas Health System is announcing plans to bring lifesaving proton therapy treatment to cancer patients in Kansas and the surrounding region. The treatment is a highly specialized, state-of-the-art form of radiation treatment, and will be offered through The University of Kansas Cancer Center for both adult and pediatric cancer patients.

"As one of the country's leading academic medical centers, bringing proton therapy to Kansas City allows us to enhance quality cancer care for everyone in the region, and to offer this care close to home," said Bob Page, president and chief executive officer of The University of Kansas Health System. Currently, there are 29 proton therapy centers in the United States. There are no centers in Kansas or the surrounding states of Iowa, Nebraska, Colorado and Arkansas.

"We are tremendously excited about the opportunity to bring proton therapy to Kansas City. This opens a new chapter for cancer care in Kansas and the surrounding region, augmenting the quality care already available through our health system," said Tammy Peterman, president of Kansas City division and executive vice president, chief operating officer, chief nursing officer for The University of Kansas Health System.
Proton therapy is an advanced form of targeted radiation treatment using protons – rather than x-rays – to attack cancerous tumors, minimizing radiation exposure to healthy organs and surrounding tissue. This personalized care offers opportunities to more precisely target treatment, with fewer short- and long-term side effects, depending on each patient's unique condition.

The therapy is most often used when precision treatment with less impact to surrounding areas is most critical, including brain, head, spine, neck, liver, prostate and central nervous system cancers as well as pediatric cancers. It also is increasingly being used in liver and esophagus cancers. Research continues to identify the most appropriate use in additional cancers, such as lung and breast. Use of proton therapy is projected to increase 62% by 2027 due to the increase in proton centers, the aging population and more indications for use.

"Our ongoing vision for The University of Kansas Health System is that no one should ever have to leave Kansas City to get the absolute best in health care. This is one more huge step forward. I am incredibly proud of our team," said Greg Graves, chair of The University of Kansas Health System's board.

Rad Oncology Homepage